NCT01932229 2013-08-30An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or GefitinibSheba Medical CenterPhase 2 Unknown20 enrolled